BioShares Biotechnology Buy or Sell Recommendation

Macroaxis provides BioShares Biotechnology Products buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BioShares Biotechnology positions. The advice algorithm takes into account all of BioShares Biotechnology Products available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from BioShares Biotechnology buy-and-hold prospective. Check also BioShares Biotechnology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Time Horizon

Risk Tolerance

Symbol
Execute Advice
BioShares Biotechnology Products -- USA Etf  

USD 40.71  0.0026  0.0064%

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding BioShares Biotechnology Products is 'Strong Sell'.
For the selected time horizon BioShares Biotechnology Products has a mean deviation of 0.754, semi deviation of 0.9636, standard deviation of 1.01, variance of 1.03, downside variance of 1.75 and semi variance of 0.9285
BioShares Biotechnology buy, hold, or sell suggestion module can be used to check and cross-verify current buy, hold, or sell recommendation provided by analysts analyzing the etf potential to grow using all of fundamental, technical, data market data available at the time. Please makes use of BioShares Biotechnology Price to Book and One Year Return to make buy, hold, or sell decision on BioShares Biotechnology.

Returns Distribution Density

Mean Return0.11Value At Risk1.31
Potential Upside1.48Standard Deviation1.01
 Return Density 
      Distribution 

BioShares Biotechnology Greeks

α
Alpha over DOW
=0.35
β
Beta against DOW=0.88
σ
Overall volatility
=1.06
Ir
Information ratio =0.18

BioShares Biotechnology Volatility Alert

BioShares Biotechnology Products has relatively low volatility with skewness of -0.53 and kurtosis of 0.25. However, we advise all investors to independently investigate BioShares Biotechnology Products to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
    
 Better Than Average     
    
 Worse Than Average Compare BioShares Biotechnology to competition
FundamentalsBioShares BiotechnologyPeer Average
Price to Earning18.03 times8.24 times
Price to Book1.66 times0.97 times
Price to Sales5.6 times0.72 times
One Year Return24.07 % (1.25) %
Three Year Return16.37 % 2.26 %
Net Asset38.48 M888.73 M
Equity Positions Weight100 % 49.22 %
SellBuy
Strong Sell

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Currently Unavailable

Piotroski F Score

Financial Leverage

Inapplicable
Risk Adjusted Performance0.0527
Market Risk Adjusted Performance(0.1)
Mean Deviation0.754
Semi Deviation0.9636
Downside Deviation1.32
Coefficient Of Variation918.64
Standard Deviation1.01
Variance1.03
Information Ratio(0.18)
Jensen Alpha0.3469
Total Risk Alpha(0.56)
Sortino Ratio(0.14)
Treynor Ratio(0.11)
Maximum Drawdown3.86
Value At Risk(1.31)
Potential Upside1.48
Downside Variance1.75
Semi Variance0.9285
Expected Short fall(0.69)
Skewness(0.53)
Kurtosis0.2523